Insiders · ZLAB

Peter Wirth

Director at Zai Lab Ltd (ZLAB)

Peter Wirth has filed 18 insider reports with the SEC since January 2021, as director at Zai Lab Ltd (ZLAB), director at Syros Pharmaceuticals, Inc. (SYRS) and director at Forma Therapeutics Holdings, Inc. (FMTX). Peter Wirth made no open-market purchases or sales in the last 12 months. The latest filing, on June 22, 2026, reports grant or award at Zai Lab Ltd (ZLAB).

Filings
18
Companies
3
Bought on market
$571K
Sold on market
$278K

Companies where Peter Wirth is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Zai Lab Ltd logo
ZLAB
Zai Lab Ltd
Director350,615$571K$278K$71.36$23.47-67%Jun 22, 2026
Syros Pharmaceuticals, Inc. logo
SYRS
Syros Pharmaceuticals, Inc.
Director16,000Mar 11, 2025
Forma Therapeutics Holdings, Inc. logo
FMTX
Forma Therapeutics Holdings, Inc.
Director0Oct 14, 2022

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Also sits on boards with

Officers and directors who share two or more companies with Peter Wirth.

Compare Peter Wirth with

Other insiders at the same companies

Questions about Peter Wirth

What is Peter Wirth's role at Zai Lab Ltd?
Peter Wirth reports to the SEC as director at Zai Lab Ltd (ZLAB), according to the latest filing on June 22, 2026. Peter Wirth has also filed as director at Syros Pharmaceuticals, Inc. (SYRS) and director at Forma Therapeutics Holdings, Inc. (FMTX).
How many shares does Peter Wirth own?
After the latest filing that states it, Peter Wirth directly owned 350,615 shares of Zai Lab Ltd (ZLAB) and 16,000 shares of Syros Pharmaceuticals, Inc. (SYRS). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Peter Wirth bought or sold stock recently?
The most recent open-market purchase was on December 8, 2021: bought 4,000 shares of Zai Lab Ltd (ZLAB) for $285K at an average of $71.36. The most recent open-market sale was on December 8, 2022: sold 7,852 shares of Zai Lab Ltd (ZLAB) for $278K at an average of $35.35.
How do I get alerts when Peter Wirth files?
Follow Peter Wirth on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Peter Wirth (SEC CIK 0001021041). Totals count each trade once, skipping amendments whose original is on file, from Jan 20, 2021 on. View on SEC EDGAR